LA JOLLA, Calif., – MyDx, Inc. (OTCQB:MYDX),producer of its patented MyDx™ (My Diagnostic) product line, the first battery operated,handheld, chemical analyzer for consumers, reported its global sales outside the USare greatly exceeding expectations, with its foreign CannaDx unit sales comprising 20% of total sales since its launch.

With only minimal MyDx marketing effort outside the US, the Company has already

received sales for CannaDx from over 20 countries, including nearly 9% from Canada and

over 3% from Spain. Given the early word of mouth and social media traction its

revolutionary multi-use Analyzer is gaining, the outlook for robust global sales is well

ahead of the Company’s initial plan. This supports the Company’s marketing objective of

building a global brand and marketplace for its multi-use MyDx Analyzer, initially with the

CannaDx application as the number of countries worldwide with legalized cannabis sales

continues to grow.

“We didn’t see it coming, not 20%, not over 20 countries, so soon,” said Daniel R.

Yazbeck, MyDx Chairman and CEO. “The first few unit sales in any new foreign country

are the most challenging to achieve. Once the seeds are planted and cannabis consumers

or prosumers (growers and dispensaries) have tried CannaDx, the word of mouth and

social media buzz in a relatively cohesive community such as the legal cannabis industry,

will grow organically.

“While it’s still early, the data paints a picture of a global market with pent-up demand

eager to affordably, accurately and conveniently test cannabis for over 20 of the most

important chemical components, including THC, that helps patients find a strain that works

for them, as well as to gain access to a growing worldwide, cloud-based cannabis

database.

“Accordingly, we are carefully examining the foreign sales data, presented above, and reanalyzing

the size and growth rates of global cannabis markets to advance our plans to

launch new marketing and distribution initiatives in Europe, Latin America, and Asia

Pacific,” Mr. Yazbeck concluded.

About MyDx

MyDx, Inc. (OTCQB:MYDX) is a chemical detection and sensor technology company

based in San Diego, California whose mission is to help people Trust & Verify™ what they

put into their minds and bodies. The Company has developed MyDx, a patented,

affordable portable analyzer that provides real-time chemical analysis and fits in the palm

of consumers’ hands. The multi-use MyDx leverages over a decade of established

electronic nose technology to measure chemicals of interest. It owns a substantial and

growing intellectual property portfolio of patents covering its technology. With its Canna

sensor commercialized, it has four other sensors being developed in its lab that are

compatible with the MyDx Analyzer and App. For more information, please

visit www.cdxlife.com.